Emma Guttman-Yassky Selected Research

Atopic Dermatitis (Atopic Eczema)

10/2022	Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials.
6/2022	Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.
5/2022	Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
1/2022	Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors.
1/2022	Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study.
1/2022	New therapies for atopic dermatitis: How will they impact skin care?
1/2022	Early intervention and prevention of allergic diseases.
1/2022	C10orf99/GPR15L Regulates Proinflammatory Response of Keratinocytes and Barrier Formation of the Skin.
1/2022	Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma.
1/2022	The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emma Guttman-Yassky Research Topics

Disease

117	Atopic Dermatitis (Atopic Eczema) 10/2022 - 11/2008
41	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 05/2007
39	Inflammation (Inflammations) 01/2022 - 03/2011
22	Alopecia Areata 10/2022 - 11/2015
14	Eczema 08/2022 - 07/2014
14	Skin Diseases (Skin Disease) 10/2021 - 06/2009
14	Pruritus (Itching) 01/2021 - 07/2014
14	Hyperplasia 11/2019 - 06/2009
9	Alopecia (Baldness) 10/2022 - 01/2017
7	Ichthyosis (Xeroderma) 10/2022 - 01/2017
7	Infections 02/2022 - 06/2004
7	Asthma (Bronchial Asthma) 01/2022 - 07/2014
7	Atherosclerosis 10/2021 - 10/2015
7	Contact Dermatitis (Eczema, Contact) 02/2019 - 02/2013
6	Allergic Contact Dermatitis 02/2019 - 02/2013
5	Neoplasms (Cancer) 01/2022 - 10/2007
4	Vitiligo 03/2022 - 11/2017
4	Conjunctivitis 01/2021 - 12/2016
3	COVID-19 01/2022 - 01/2021
3	Chronic Urticaria 01/2022 - 10/2006
3	Dermatitis 01/2022 - 01/2018
3	Headache (Headaches) 01/2021 - 07/2014
3	Nasopharyngitis 01/2021 - 07/2014
3	Hypersensitivity (Allergy) 01/2020 - 10/2017
3	Injection Site Reaction 01/2020 - 12/2016
2	Acne Vulgaris 10/2022 - 01/2021
2	Body Weight (Weight, Body) 05/2022 - 01/2020
2	Netherton Syndrome 01/2022 - 01/2019
2	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 01/2022 - 01/2019
2	Lamellar Ichthyosis (Harlequin Ichthyosis) 01/2022 - 01/2019
2	Congenital Ichthyosiform Erythroderma 01/2022 - 01/2019
2	Pain (Aches) 10/2021 - 10/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

38	CytokinesIBA 01/2022 - 05/2007
29	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2011
28	dupilumabIBA 10/2022 - 07/2014
18	Interleukin-17 (Interleukin 17)IBA 02/2022 - 11/2008
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
14	Interleukin-13IBA 01/2021 - 06/2014
10	Interleukin-22 (IL-22)IBA 04/2019 - 11/2008
8	Janus KinasesIBA 01/2022 - 04/2019
8	Interleukin-4 (Interleukin 4)IBA 01/2021 - 10/2007
7	SaltsIBA 10/2022 - 01/2019
7	Janus Kinase InhibitorsIBA 01/2022 - 01/2019
7	Filaggrin ProteinsIBA 01/2022 - 01/2017
7	Biological ProductsIBA 01/2022 - 04/2013
7	Pharmaceutical PreparationsIBA 01/2022 - 10/2006
7	Keratin-16 (Keratin 16)IBA 01/2019 - 12/2016
6	Monoclonal AntibodiesIBA 01/2022 - 07/2014
6	Immunoglobulin E (IgE)IBA 01/2020 - 11/2015
6	Interleukin-23 (Interleukin 23)IBA 04/2019 - 11/2008
6	Messenger RNA (mRNA)IBA 01/2018 - 11/2008
5	upadacitinibIBA 10/2022 - 01/2020
5	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2015
5	AntigensIBA 01/2022 - 09/2011
5	AllergensIBA 01/2020 - 08/2014
5	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2020 - 12/2016
5	Ustekinumab (CNTO 1275)FDA Link 03/2018 - 01/2015
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 05/2007
4	Immunoglobulin A (IgA)IBA 05/2022 - 01/2020
4	apremilastIBA 03/2022 - 01/2019
4	InterleukinsIBA 10/2021 - 01/2019
4	SteroidsIBA 01/2021 - 01/2016
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021 - 05/2007
4	LipidsIBA 01/2021 - 01/2018
4	ChemokinesIBA 01/2020 - 05/2007
4	loricrinIBA 01/2019 - 01/2018
4	Interleukin-12 (IL 12)IBA 01/2017 - 10/2007
3	secukinumabIBA 02/2022 - 10/2018
3	fezakinumabIBA 01/2022 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
3	abrocitinibIBA 11/2021 - 12/2020
3	tralokinumabIBA 09/2021 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2006
3	AntibodiesIBA 01/2020 - 06/2011
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2019 - 04/2016
3	Irritants (Vesicants)IBA 02/2019 - 02/2013
3	NickelIBA 02/2019 - 08/2014
3	6-sulfo sialyl Lewis XIBA 01/2019 - 10/2015
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 06/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2021
2	Antimicrobial PeptidesIBA 10/2022 - 06/2009
2	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022 - 01/2021
2	VaccinesIBA 01/2022 - 11/2008
2	Imiquimod (Aldara)FDA LinkGeneric 01/2022 - 10/2019
2	Peptides (Polypeptides)IBA 01/2022 - 01/2022
2	Omalizumab (Xolair)FDA Link 01/2022 - 01/2021
2	LigandsIBA 01/2022 - 05/2007
2	Interleukin-10 (Interleukin 10)IBA 11/2021 - 10/2007
2	baricitinibIBA 07/2021 - 04/2019
2	Janus Kinase 1IBA 07/2021 - 01/2020
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2021 - 01/2017
2	E-SelectinIBA 01/2020 - 10/2015
2	Interleukin-9 (Interleukin 9)IBA 01/2020 - 01/2019
2	crisaboroleIBA 11/2019 - 04/2016
2	Ointments (Pastes)IBA 11/2019 - 04/2016

Therapy/Procedure

41	Therapeutics 10/2022 - 03/2011
3	Aftercare (After-Treatment) 10/2022 - 01/2020
2	Immunotherapy 01/2022 - 02/2019
2	Precision Medicine 01/2022 - 12/2021